102 ABSTRACT OBJECTIVE Hypertension is a highly common cardiovascular risk factor, and a large proportion of patients with coronary heart disease (CHD) have uncontrolled hypertension. We report on the distribution and determinants of hypertension awareness, treatment, and control in CHD patients with hypertension. METHODS The EUROASPIRE V survey included 8261 CHD patients from 27 countries. Awareness was defined as patients reporting being told by a health professional to have raised blood pressure (BP), being aware of their BP target and latest measurement. Patients using antihypertensive medication to lower BP were considered treated. Controlled hypertension was defined as BP <140/90mmHg (<140/85mmHg in diabetics). Factors associated with hypertension awareness, treatment and control were identified with logistic regression. RESULTS A total of 6547 EUROASPIRE V patients were considered hypertensive, from which 59.9% were aware, 91.1% were on treatment, and 46.4% were controlled. Number of antihypertensive drugs and adherence were independently associated with awareness (number medications OR 1.24, 95%CI 1.17-1.31, adherence 2.26, 1.81-2.82) and control (number medications 1.11, 1.06-1.17, adherence 1.97, 1.60-2.42). Awareness was associated with secondary (1.34, 1.05-1.71) and tertiary (1.70, 1.33-2.17) education and undertaking lifestyle changes (1.59, 1.36-1.86), and controlled patients were more often aware (1.47, 1.27-1.70) and had a healthier risk factor profile (BMI >25kg/m2 0.73, 0.62-0.87, diabetes 0.65, 0.57-0.74, LDL ≥1.8mmol/L 0.75, 0.65-0.87) than uncontrolled patients. CONCLUSION Hypertension control remains poor in hypertensive CHD patients, despite high treatment and reasonable awareness levels. Communication with CHD patients with hypertension, especially those from vulnerable groups, needs to improve to facilitate change of health behaviors. KEYWORDS CHD, secondary prevention, hypertension, hypertension treatment, hypertension awareness, hypertension control, medication, risk factors
RkJQdWJsaXNoZXIy MTk4NDMw